Single-agent dabrafenib for BRAF(V600E)-mutated histiocytosis

類似資料

• RARE-22. SINGLE-AGENT DABRAFENIB FOR INTRACRANIAL BRAF(V600E)-MUTATED HISTIOCYTOSIS
  著者:: Bhatia, Ankush, 等
  出版事項: (2017)
• Effectiveness and Safety of Dabrafenib in the Treatment of 20 Chinese Children with BRAF(V600E)-Mutated Langerhans Cell Histiocytosis
  著者:: Yang, Ying, 等
  出版事項: (2021)
• Neurologic and oncologic features of Erdheim–Chester disease: a 30-patient series
  著者:: Bhatia, Ankush, 等
  出版事項: (2020)
• Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer
  著者:: Corcoran, Ryan B., 等
  出版事項: (2015)
• Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study
  著者:: Diamond, Eli L., 等
  出版事項: (2017)